Global Cardiac Ablation Strategic Research Report 2024: Technological Advancements Broaden Adoption of Cardiac Ablation Technology – Forecasts to 2030
DUBLIN, Feb. 15, 2024 /PRNewswire/ — The “Cardiac Ablation – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Cardiac Ablation Market to Reach $2.4 Billion by 2030
The global market for Cardiac Ablation estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$2.4 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030. Radiofrequency (RF) Ablation, one of the segments analyzed in the report, is projected to record 11.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Electrical Ablation segment is estimated at 9.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $522.7 Million, While China is Forecast to Grow at 15.2% CAGR
The Cardiac Ablation market in the U.S. is estimated at US$522.7 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$196.5 Million by the year 2030 trailing a CAGR of 15.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 9.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
What`s New?
Special discussions on the global economic climate and market sentimentCoverage on global competitiveness and key competitor percentage market sharesMarket presence analysis across multiple geographies – Strong/Active/Niche/TrivialOnline interactive peer-to-peer collaborative bespoke updatesAccess to digital archives and trademarked research platformComplimentary updates for one yearAccess to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Topics Covered:
MARKET OVERVIEW
Influencer Market InsightsWorld Market TrajectoriesAn Introduction to Cardiac AblationTypes of Cardiac Ablation TechnologiesRadiofrequency (RF) AblationElectrical Energy-Based AblationCryoablationUltrasound Energy-Based AblationMicrowave Energy-based AblationCardiac Ablation Market: Growth Prospects and OutlookEmerging Markets Forecast to Post High GrowthCardiac Ablation – Global Key Competitors Percentage Market Share in 2022 (E)Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)Impact of Covid-19 and a Looming Global Recession
FOCUS ON SELECT PLAYERS (Total 16 Featured)
Abbott Laboratories (USA)AtriCure, Inc. (USA)Biosense Webster Inc. (USA)Boston Scientific Corporation (USA)CardioFocus, Inc. (USA)Kardium, Inc. (Canada)Medtronic Plc (Ireland)Shanghai MicroPort EP MedTech Co., Ltd. (China)
MARKET TRENDS & DRIVERS
Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Fuel Cardiac Surgical Volumes Fuel Growth in the Cardiac Ablation MarketLeading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017Leading Causes of Mortality for Low-Income and High-Income CountriesGlobal Cardiology and Cardiac Surgery Market: Revenues in US$ Billion for the Years 2017, 2019, 2021 and 2023Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac Ablation MarketExpanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030As Cardiovascular Disease Prevalence Increases at a Strong Rate in Developing Economies, Tremendous Potential Exists for Cardiac Ablation MarketGrowing Significance of Cardiac Ablation for Cardiac Rhythm ManagementRising Incidence of Atrial Fibrillation: An Opportunity for Cardiac Ablation MarketIncidence of Atrial Fibrillation Per Million Population in United States (in %): 2000-2020Ranking of Factors for Incidence of Atrial FibrillationInnovative Technologies Assist in Enhancing AF Ablation ProcessAblation Found to be Effective for AF Compared to MedicationsAblation Technology for Supra-venticular TachycardiaShift towards Minimally Invasive Surgeries Fuels Demand for Cardiac Ablation ProceduresMinimally Invasive Catheter Ablation Continues to Gain Prominence in Cardiac ProceduresRF Ablation Emerges as a Preferred Treatment Option for Cardiac ArrhythmiasCryoablation for Treatment of AF: Minimally Invasive Procedure Favors AdoptionMRI-Guided Cardiac Ablation MarketHybrid Ablation Procedure for Treatment of Atrial Fibrillation: Addressing the Limitations of Traditional TreatmentsTechnological Advancements Broaden Adoption of Cardiac Ablation TechnologyAdvanced 3D Electrophysiology Mapping and Imaging SystemsCryoballoon Ablation CathetersLaser Balloon Ablation CathetersContact-Force Technology
For more information about this report visit https://www.researchandmarkets.com/r/5y3y69
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets